Entry |
|
Name |
Beroterkib (USAN); Beroterkib hydrate |
Formula |
C29H31ClFN5O5. H2O
|
Exact mass |
601.2103
|
Mol weight |
602.05
|
Structure |

|
Efficacy |
Antineoplastic, Extracellular signal-regulated kinase inhibitor |
Target |
|
Pathway |
|
Brite |
Target-based classification of drugs [BR:br08310]
Protein kinases
Serine/threonine kinases
CMGC group
ERK
D12865 Beroterkib (USAN)
|
Other DBs |
|
LinkDB |
|
KCF data |
ATOM 42
1 C8x C 32.5726 -17.6126
2 C8y C 32.5726 -16.2096
3 C8x C 33.7652 -15.5081
4 C8y C 35.0279 -16.2096
5 C8y C 35.0279 -17.6126
6 C8x C 33.7652 -18.3141
7 C5x C 36.3607 -15.7887
8 N1y N 37.1324 -16.9111
9 C1x C 36.3607 -18.0335
10 O5x O 36.7816 -14.4558
11 C1c C 38.5354 -16.9111
12 C1a C 39.2369 -18.1036
13 C5a C 39.2369 -15.7185
14 N1b N 40.6399 -15.7185
15 O5a O 38.5354 -14.5260
16 C1c C 41.3414 -14.5260
17 C8y C 42.7444 -14.5260
18 C1b C 40.6399 -13.3334
19 O1a O 39.2369 -13.3334
20 C8x C 43.4459 -15.7185
21 C8y C 44.8489 -15.7185
22 C8x C 45.5504 -14.5260
23 C8y C 44.8489 -13.2633
24 C8x C 43.4459 -13.2633
25 O2a O 45.5504 -12.0707
26 C1a C 46.9534 -12.0707
27 X F 45.5504 -16.9111
28 C8y C 31.3801 -15.5081
29 C8y C 31.3801 -14.1051
30 C8x C 30.1875 -13.4036
31 N5x N 28.9248 -14.1051
32 C8y C 28.9248 -15.5081
33 N5x N 30.1875 -16.2096
34 X Cl 32.5726 -13.4036
35 N1b N 27.7323 -16.2096
36 C1y C 26.5397 -15.5081
37 C1x C 26.5397 -14.1051
38 C1x C 25.2770 -13.4036
39 O2x O 24.0845 -14.1051
40 C1x C 24.0845 -15.5081
41 C1x C 25.2770 -16.2096
42 O0 O 48.0900 -18.2700
BOND 45
1 1 2 2
2 2 3 1
3 3 4 2
4 4 5 1
5 5 6 2
6 1 6 1
7 4 7 1
8 7 8 1
9 8 9 1
10 5 9 1
11 7 10 2
12 11 12 1 #Up
13 11 13 1
14 13 14 1
15 13 15 2
16 14 16 1
17 16 17 1
18 16 18 1 #Down
19 18 19 1
20 17 20 2
21 20 21 1
22 21 22 2
23 22 23 1
24 23 24 2
25 17 24 1
26 23 25 1
27 25 26 1
28 21 27 1
29 11 8 1
30 28 2 1
31 28 29 2
32 29 30 1
33 30 31 2
34 31 32 1
35 32 33 2
36 28 33 1
37 29 34 1
38 32 35 1
39 35 36 1
40 36 37 1
41 37 38 1
42 38 39 1
43 39 40 1
44 40 41 1
45 36 41 1
|